2RNZ

Solution structure of the presumed chromodomain of the yeast histone acetyltransferase, Esa1

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.1mM CHROMODOMAIN [U-99% 13C; U-99% 15N], 200mM potassium phosphate, 5mM D-DTT	90% H2O/10% D2O		6.8	AMBIENT	295
2	3D CBCA(CO)NH	0.1mM CHROMODOMAIN [U-99% 13C; U-99% 15N], 200mM potassium phosphate, 5mM D-DTT	90% H2O/10% D2O		6.8	AMBIENT	295
3	3D HNCACB	0.1mM CHROMODOMAIN [U-99% 13C; U-99% 15N], 200mM potassium phosphate, 5mM D-DTT	90% H2O/10% D2O		6.8	AMBIENT	295
4	3D HNCO	0.1mM CHROMODOMAIN [U-99% 13C; U-99% 15N], 200mM potassium phosphate, 5mM D-DTT	90% H2O/10% D2O		6.8	AMBIENT	295
5	3D HNCA	0.1mM CHROMODOMAIN [U-99% 13C; U-99% 15N], 200mM potassium phosphate, 5mM D-DTT	90% H2O/10% D2O		6.8	AMBIENT	295
6	3D HN(CO)CA	0.1mM CHROMODOMAIN [U-99% 13C; U-99% 15N], 200mM potassium phosphate, 5mM D-DTT	90% H2O/10% D2O		6.8	AMBIENT	295
7	2D 1H-13C HSQC	0.1mM CHROMODOMAIN [U-99% 13C; U-99% 15N], 200mM potassium phosphate, 5mM D-DTT	100% D2O		6.8	AMBIENT	295
8	3D HCCH-TOCSY	0.1mM CHROMODOMAIN [U-99% 13C; U-99% 15N], 200mM potassium phosphate, 5mM D-DTT	100% D2O		6.8	AMBIENT	295
9	3D 1H-15N NOESY	0.1mM CHROMODOMAIN [U-99% 13C; U-99% 15N], 200mM potassium phosphate, 5mM D-DTT	90% H2O/10% D2O		6.8	AMBIENT	295
10	3D 1H-13C NOESY	0.1mM CHROMODOMAIN [U-99% 13C; U-99% 15N], 200mM potassium phosphate, 5mM D-DTT	100% D2O		6.8	AMBIENT	295

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	800
3	Varian	INOVA	900

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	600
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CYANA	2.1	P.GUNTERT ET AL.
2	chemical shift assignment	Olivia		Yokochi, M., Sekiguchi, S. and Inagaki, F.
3	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.